Schizophrenia
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
118
|
269
|
0.500 |
None |
0.750 |
3 |
2
|
2000 |
2019 |
Rheumatoid Arthritis
|
disease |
Skin and Connective Tissue Diseases; Musculoskeletal Diseases; Immune System Diseases
|
Disease or Syndrome
|
282
|
1613
|
0.150 |
None |
1.000 |
3 |
23
|
2001 |
2013 |
Multiple Sclerosis
|
disease |
Immune System Diseases; Nervous System Diseases
|
Disease or Syndrome
|
201
|
488
|
0.130 |
None |
1.000 |
2 |
3
|
2004 |
2013 |
Systemic Scleroderma
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
40
|
78
|
0.120 |
None |
1.000 |
2 |
3
|
2010 |
2016 |
Age related macular degeneration
|
disease |
Eye Diseases
|
Disease or Syndrome
|
38
|
279
|
0.110 |
None |
< 0.001 |
1 |
2
|
2012 |
2012 |
Adenocarcinoma of lung (disorder)
|
disease |
Neoplasms
|
Neoplastic Process
|
43
|
80
|
0.110 |
None |
0.500 |
1 |
1
|
2009 |
2016 |
Narcolepsy
|
disease |
Nervous System Diseases; Mental Disorders
|
Disease or Syndrome
|
202
|
436
|
0.110 |
None |
1.000 |
1 |
2
|
1997 |
2009 |
Lupus Erythematosus, Systemic
|
disease |
Skin and Connective Tissue Diseases; Immune System Diseases
|
Disease or Syndrome
|
109
|
253
|
0.110 |
None |
1.000 |
1 |
2
|
2012 |
2014 |
Asthma
|
disease |
Respiratory Tract Diseases; Immune System Diseases
|
Disease or Syndrome
|
110
|
263
|
0.110 |
None |
1.000 |
1 |
1
|
2011 |
2019 |
AIDS, PROGRESSION TO
|
phenotype |
|
Finding
|
61
|
365
|
0.100 |
None |
1.000 |
2 |
2
|
2009 |
2010 |
ACQUIRED IMMUNODEFICIENCY SYNDROME, PROGRESSION TO
|
phenotype |
|
Finding
|
61
|
365
|
0.100 |
None |
1.000 |
2 |
2
|
2009 |
2010 |
HIV-1, RESISTANCE TO
|
phenotype |
|
Finding
|
61
|
365
|
0.100 |
None |
1.000 |
2 |
2
|
2009 |
2010 |
HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO
|
disease |
|
Finding
|
61
|
365
|
0.100 |
None |
1.000 |
2 |
2
|
2009 |
2010 |
Pemphigus Vulgaris
|
disease |
Skin and Connective Tissue Diseases; Immune System Diseases
|
Disease or Syndrome
|
6
|
23
|
0.100 |
None |
1.000 |
1 |
2
|
2012 |
2012 |
Myeloperoxidase Measurement
|
phenotype |
|
Laboratory Procedure
|
15
|
16
|
0.100 |
None |
1.000 |
1 |
1
|
2013 |
2013 |
C4 complement assay (procedure)
|
phenotype |
|
Laboratory Procedure
|
7
|
10
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Malignant neoplasm of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
66
|
166
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Pulmonary function
|
phenotype |
|
Organ or Tissue Function
|
41
|
259
|
0.100 |
None |
1.000 |
1 |
1
|
2010 |
2010 |
Polysomnography
|
phenotype |
|
Diagnostic Procedure
|
117
|
247
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Diabetes Mellitus, Insulin-Dependent
|
disease |
Nutritional and Metabolic Diseases; Immune System Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
143
|
477
|
0.100 |
None |
1.000 |
1 |
12
|
2007 |
2007 |
Vitiligo
|
disease |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
61
|
121
|
0.100 |
None |
1.000 |
1 |
2
|
2010 |
2010 |
Myasthenia Gravis
|
disease |
Neoplasms; Immune System Diseases; Nervous System Diseases
|
Disease or Syndrome
|
35
|
56
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Sarcoidosis
|
disease |
Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
20
|
697
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Pulmonary function (finding)
|
phenotype |
|
Finding
|
41
|
259
|
0.100 |
None |
1.000 |
1 |
1
|
2010 |
2010 |